SBRT FOR LARGE STAGE I LUNG TUMOURS: OPTIMIZING VOLUMETRIC MODULATED ARC PLANNING OBJECTIVES USING CLINICAL TOXICITY DATA

被引：0
|
作者：
Verbakel, W. [1 ]
Ong, C. L. [1 ]
Palma, D. [1 ]
Slotman, B. [1 ]
Senan, S. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Radiat Oncol, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1039
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [41] On the Clinical and Dosimetric Accuracy of Recently Released Advanced Dose Calculation Algorithm and Analytical Anisotropic Algorithm (AAA) Photon Dose Calculation Algorithms for SBRT Lung Treatment With Volumetric Modulated Arc Therapy (VMAT)
    Khodri, M.
    Largeron, G.
    Nguyen, D.
    Lorchel, F.
    Passerat, V.
    Pouchard, I.
    Barbet, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S825 - S825
  • [42] STEREOTACTIC BODY RADIOTHERAPY (SBRT) USING VOLUMETRIC MODULATED ARC THERAPY (VMAT) WITH FLATTENING FILTER FREE (FFF) MODALITY FOR MEDICALLY INOPERABLE EARLY STAGE NON SMALL-CELL LUNG CANCER (NSCLC): A PROSPECTIVE SINGLE INSTITUTIONAL EXPERIENCE
    Navarria, P.
    Ascolese, A. M.
    Clerici, E.
    Reggiori, G.
    Catalano, M.
    Pentimalli, S.
    Castiglioni, S.
    Alongi, F.
    Mancosu, P.
    Scorsetti, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S49 - S49
  • [43] First Clinical Results of 3D Verification of Volumetric-Modulated Arc Therapy (VMAT) of Prostate and Lung Cancer Patients Using EPID Dosimetry
    Mijnheer, B.
    Mans, A.
    Olaciregui-Ruiz, I.
    Sonke, J.
    Stroom, J.
    Tielenburg, R.
    Herk, M.
    Vijlbrief, R.
    [J]. MEDICAL PHYSICS, 2010, 37 (06) : 3351 - +
  • [44] Dosimetric analysis of cervical cancer stage IIB patients treated with volumetric modulated arc therapy using plan uncertainty parameters module of Varian Eclipse treatment planning system
    Singh, Gaganpreet
    Tyagi, Atul
    Thaper, Deepak
    Kamal, Rose
    Kumar, Vivek
    Oinam, Arun S.
    Srivastava, Ranjana
    Halder, Shikha
    Hukku, Shelly
    [J]. BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2021, 7 (03):
  • [45] Clinical Outcomes and Toxicity After Stereotactic Body Radiation Therapy (SBRT) With or Without Adjuvant Chemotherapy for Stage I Non-small Cell Lung Cancer (NSCLC)
    Vance, S.
    Yes, H.
    Baschnagel, A.
    Mangona, V.
    Yan, D.
    Grills, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S590 - S590
  • [46] A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy
    Ishii, Kentaro
    Okada, Wataru
    Ogino, Ryo
    Kubo, Kazuki
    Kishimoto, Shun
    Nakahara, Ryuta
    Kawamorita, Ryu
    Ishii, Yoshie
    Tada, Takuhito
    Nakajima, Toshifumi
    [J]. JOURNAL OF RADIATION RESEARCH, 2016, 57 (03) : 273 - 279
  • [47] Comparison of dose metrics between automated and manual radiotherapy planning for advanced stage non-small cell lung cancer with volumetric modulated arc therapy (vol 9, pg 92, 2019)
    Tetar, S. U.
    [J]. PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2020, 15 : 98 - 98
  • [48] Robustness assessment using probabilistic scenarios of intensity modulated proton therapy and volumetric arc therapy in non-small-cell lung cancer: an in-silico radiotherapy planning study
    Teoh, Suliana
    George, Ben
    Fiorini, Francesca
    Vallis, Katherine
    Van den Heuvel, Frank
    [J]. LANCET, 2017, 389 : 94 - 94
  • [49] Feasibility of Robust Optimization in Volumetric Modulated Arc Therapy Using 6 and 10 MV Flattening Filter-Free Beam Therapy Planning for Lung Stereotactic Body Radiation Therapy
    Miura, H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E293 - E294
  • [50] Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma (vol 43, pg 140, 2020)
    Liu, Xianfeng
    Wang, Ying
    Guo, Qishuai
    Luo, Huanli
    Luo, Qian
    Li, Qicheng
    Wu, Zhijuan
    Jin, Fu
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (04) : 175 - 175
12345